BiotechTube

psyllium fibre (dietary supplement) + wheat bran (dietary supplement) + rice wheat (placebo)

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Colonic Diseases, Functional

Conditions

Colonic Diseases, Functional

Trial Timeline

Apr 1, 2005 → Apr 1, 2007

NCT ID
NCT00189033

About psyllium fibre (dietary supplement) + wheat bran (dietary supplement) + rice wheat (placebo)

psyllium fibre (dietary supplement) + wheat bran (dietary supplement) + rice wheat (placebo) is a pre-clinical stage product being developed by Pfizer for Colonic Diseases, Functional. The current trial status is completed. This product is registered under clinical trial identifier NCT00189033. Target conditions include Colonic Diseases, Functional.

What happened to similar drugs?

2 of 3 similar drugs in Colonic Diseases, Functional were approved

Approved (2) Terminated (1) Active (1)
✅Methylnaltrexone Bromide (MNTX) + PlaceboPfizerApproved
✅oxaliplatinSanofiApproved
🔄Oxaliplatin (SR96669)SanofiPhase 3

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00189033Pre-clinicalCompleted

Competing Products

6 competing products in Colonic Diseases, Functional

See all competitors
ProductCompanyStageHype Score
Enzastaurin HClEli LillyPhase 2
35
Entereg + Entereg + placeboMerckPhase 2
35
Indium labeled IMP-205xm734Gilead SciencesPhase 1
29
Methylnaltrexone Bromide (MNTX) + PlaceboPfizerApproved
35
oxaliplatinSanofiApproved
43
Oxaliplatin (SR96669)SanofiPhase 3
40